Proteome of human perilymph

Area of Science:

• Otorhinolaryngology
• Proteomics
• Biochemistry

Background:

• Current diagnostic methods for sensorineural hearing loss are insufficient, often leading to idiopathic diagnoses.
• This lack of precise diagnosis hinders prognosis and limits treatment options for patients.
• Developing advanced diagnostic tools is crucial for improving patient care in audiology.

Purpose of the Study:

• To establish the proteomic profile of human perilymph using liquid chromatography-tandem mass-spectrometry (LC-MS/MS).
• To identify potential protein biomarkers for vestibular schwannoma (VS) by comparing patient samples.
• To lay the groundwork for novel diagnostic strategies for hearing loss.

Main Methods:

• Analysis of human perilymph samples from patients with vestibular schwannoma (VS) and cochlear implantation (CI) using LC-MS/MS.
• Identification of common proteins to define the human perilymph proteome.
• Comparative proteomic analysis between VS and CI patient samples.

Main Results:

• Successfully mapped the human perilymph proteome, identifying 271 high-confidence proteins.
• Defined a core set of 71 proteins consistently present across all analyzed perilymph samples.
• Identified 15 candidate protein biomarkers differentiating VS from CI samples.

Conclusions:

• LC-MS/MS is a viable method for perilymph proteome analysis.
• The identified biomarkers offer potential for future diagnostic tools to distinguish VS subtypes.
• This research represents a significant step toward improved diagnosis and management of hearing loss.